AstraZeneca's top-selling drug slows early-stage lung cancer - trial

AstraZeneca's top-selling drug Tagrisso has been shown to hold back a certain type of lung cancer when diagnosed at an early stage, the British drugmaker said on Thursday, potentially adding billions to its sales potential.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news